Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation
Almenar-Perez, Eloy; Ovejero, Tamara; Sanchez-Fito, Teresa; Espejo, Jose A.; Nathanson, Lubov; Oltra, Elisa
CLINICAL THERAPEUTICS
2019
VL / 41 - BP / 675 - EP / 698
abstract
Purpose: Studies to determine epigenetic changes associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) remain scarce; however, current evidence clearly shows that methylation patterns of genomic DNA and noncoding RNA profiles of immune cells differ between patients and healthy subjects, suggesting an active role of these epigenetic mechanisms in the disease. The present study compares and contrasts the available ME/CFS epigenetic data in an effort to evidence overlapping pathways capable of explaining at least some of the dysfunctional immune parameters linked to this disease. Methods: A systematic search of the literature evaluating the ME/CFS epigenome landscape was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. Differential DNA methylation and noncoding RNA differential expression patterns associated with ME/CFS were used to screen for the presence of transposable elements using the Dfam browser, a search program nurtured with the Repbase repetitive sequence database and the RepeatMasker annotation tool. Findings: Unexpectedly, particular associations of transposable elements and ME/CFS epigenetic hallmarks were uncovered. A model for the disease emerged involving transcriptional induction of endogenous dormant transposons and structured cellular RNA interactions, triggering the activation of the innate immune system without a concomitant active infection. (C) 2019 Elsevier Inc. All rights reserved.
MENTIONS DATA
Pharmacology & Toxicology
-
0 Twitter
-
0 Wikipedia
-
0 News
-
95 Policy
Among papers in Pharmacology & Toxicology
Más información
Influscience
Rankings
- BETA VERSION